Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Equity (2016 - 2025)

Macrogenics (MGNX) has disclosed Return on Equity for 13 consecutive years, with 1.24% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 65.0% to 1.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.24% through Dec 2025, down 65.0% year-over-year, with the annual reading at 0.87% for FY2025, 37.0% down from the prior year.
  • Return on Equity for Q4 2025 was 1.24% at Macrogenics, up from 1.37% in the prior quarter.
  • The five-year high for Return on Equity was 0.39% in Q2 2021, with the low at 2.38% in Q2 2024.
  • Average Return on Equity over 5 years is 0.96%, with a median of 0.84% recorded in 2021.
  • The sharpest move saw Return on Equity tumbled -169bps in 2024, then skyrocketed 178bps in 2025.
  • Over 5 years, Return on Equity stood at 0.76% in 2021, then fell by -20bps to 0.92% in 2022, then fell by -7bps to 0.98% in 2023, then surged by 40bps to 0.59% in 2024, then tumbled by -111bps to 1.24% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.24%, 1.37%, and 0.61% for Q4 2025, Q3 2025, and Q2 2025 respectively.